Study Finds That BRAF Inhibitors Could be an Effective Treatment for Some Ovarian Cancer Patients
felixioncool / Pixabay

Study Finds That BRAF Inhibitors Could be an Effective Treatment for Some Ovarian Cancer Patients

According to a story from news-medical.net, a recent study suggests that a class of drugs called BRAF inhibitors could be an effective treatment option for ovarian cancer patients who carry…

Continue Reading Study Finds That BRAF Inhibitors Could be an Effective Treatment for Some Ovarian Cancer Patients
So Why DOES Canada have Scarcer Access to Rare Disease Therapies?
FrankWinkler / Pixabay

So Why DOES Canada have Scarcer Access to Rare Disease Therapies?

According to a story from CheckOrphan, Durhane Wong-Rieger, the CEO of the Canadian Organization for Rare Disorders, says that the Canadian health system has been letting down the roughly three…

Continue Reading So Why DOES Canada have Scarcer Access to Rare Disease Therapies?
What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors
IADE-Michoko / Pixabay

What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors

On August 16th, 2018, Aretha Franklin, the "Queen of Soul," passed away at age 76. Aretha will be immortalized for generations because of the success of her classic soul ballads…

Continue Reading What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors
Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors
12019 / Pixabay

Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors

  The survival rates for infants and children with brain and spinal cord cancer has improved significantly over the past decades. However, a study published online in early August of…

Continue Reading Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors
An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation
stevepb / Pixabay

An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation

The US FDA has awarded Breakthrough Therapy Designation to encorafenib (braftoviTM) combined with binimetinib (mektovi®) and cetuximab for use as an investigational (not FDA-approved) treatment of BRAFV600E–mutant metastatic colorectal cancer.…

Continue Reading An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation

This SLP’s Mission to Expand Resources for Those with ALS, Muscular Dystrophy, and More

  According to ASHA.org, when Tiffany Turner graduated, she set out to expand opportunities for fellow speech language pathologists like herself. Turner saw a great need in her community for…

Continue Reading This SLP’s Mission to Expand Resources for Those with ALS, Muscular Dystrophy, and More

The FDA Have Granted Priority Review to Elzonris for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

  A Biologics License Application for ElzonrisTM (also known as tagraxofusp and SL-401) for the treatment of blastic plasmacytoid dendritic cell neoplasm has been accepted for filing by the United States FDA.…

Continue Reading The FDA Have Granted Priority Review to Elzonris for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV
Rainer_Maiores / Pixabay

Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV

Researchers are exploring a new diagnostic method that could be applied to newborn screening for certain inherited diseases and monitoring of HIV patients. For more detailed information, you can click…

Continue Reading Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV

Results from First Study on Patient-To-Patient Connectivity in Those with FCS

  According to DAIC, Akcea Therapeutics Inc., has recently announced their publication of results from their study analyzing patient-to-patient connectivity towards the management of the rare disease familial chylomicronemia syndrome (FCS).…

Continue Reading Results from First Study on Patient-To-Patient Connectivity in Those with FCS